EGFR and non-small cell lung carcinoma: Quinolines 6 and 7 (Figure 1) were found to be highly active kinase inhibitors in biochemical assays and were further investigated for their biological effect on EGFR-dependent Ba/F3 cells and non-small cell lung cancer (NSCLC) cell lines [13].